Načítá se...

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer

BACKGROUND: MicroRNAs (miRs) are small RNA molecules, influencing messenger RNA (mRNA) expression and translation, and are readily detectable in blood. Some have been reported as potential breast cancer biomarkers. This study aimed to identify and validate miRs indicative of breast cancer. RESULTS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Lagendijk, Mirelle, Sadaatmand, Sepideh, Koppert, Linetta B., Tilanus-Linthorst, Madeleine M.A., de Weerd, Vanja, Ramírez-Moreno, Raquel, Smid, Marcel, Sieuwerts, Anieta M., Martens, John W.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966243/
https://ncbi.nlm.nih.gov/pubmed/29849944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25262
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!